Protein–energy supplementation of normal hospital diet did not improve outcomes after recent strokePDF
ACP J Club. 2005 Sep-Oct;143:36. doi:10.7326/ACPJC-2005-143-2-036
Related Content in this Issue
• Companion Abstract and Commentary: Timing and route of enteral tube-feeding did not reduce death or poor outcome in stroke and dysphagia
Clinical Impact Ratings
Phys Med & Rehab:
The FOOD Trial Collaboration. Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial. Lancet. 2005;365:755-63. [PubMed ID: 15733716]
Does routine oral protein–energy supplementation of normal hospital diet improve outcomes in patients who have been admitted with a recent stroke and can swallow?
Design: Randomized controlled trial (Feed Or Ordinary Diet [FOOD] trials).
Blinding: Blinded (outcome assessors).*
Follow-up period: Median 6.7 months.
Setting: 125 hospitals in 15 countries.
Patients: 4023 patients (mean age 71 y, 53% men, 8% undernourished) who were admitted with a recent stroke (first or recurrent stroke ≤ 7 d before admission) and whose clinicians were uncertain about whether to use oral nutritional supplements after they had passed the swallow screen. Patients with subarachnoid hemorrhage were excluded. Patients could be enrolled within the first 30 days of admission, or within 30 days of stroke occurring in hospital.
Intervention: Normal hospital diet plus oral protein–energy supplements (equivalent to 360 mL at 6.27 kJ/mL and 62.5 g/L in protein every d) (n = 2016) or normal hospital diet alone (n = 2007) until discharge.
Outcomes: A composite endpoint of all-cause mortality or poor outcome (defined as modified Rankin scale [MRS] scores 3 to 5, with the MRS scores ranging from 0 [no symptoms] to 5 [requiring constant attention day and night]), and all-cause mortality.
Patient follow-up: 99.7% (intention-to-treat analysis).
The groups did not differ for rates of the composite endpoint or all-cause mortality (Table).
Routine oral protein–energy supplementation of normal hospital diet did not improve outcomes in patients who had been admitted with a recent stroke.
Sources of funding: National Health Service Research and Development in UK; Stroke Association; Chief Scientist Office of the Scottish Executive; Chest, Heart and Stroke Scotland; Royal Australian College of Physicians.
For correspondence: Professor M. Dennis, Western General Hospital, Edinburgh, Scotland, UK. E-mail firstname.lastname@example.org.
Table. Normal hospital diet plus oral protein–energy supplements vs normal hospital diet after recent stroke at median 6.7 months†
|Outcomes||Supplements||No supplements||RRI (95% CI)||NNH|
|Composite endpoint||59%||58%||1.5% (−3.6 to 6.9)||Not significant|
|All-cause mortality||12%||13%||5.2% (−11.8 to 19.6)||Not significant|
†Composite endpoint = all-cause mortality or poor outcome defined as modified Rankin scale scores 3 to 5 (range 0 to 5). Abbreviations defined in Glossary; RRI, RRR, NNH, NNT, and CI calculated from data in article.
The 3 FOOD trials by The Food Trial Collaboration add to the evidence base of how best to feed patients with stroke. The protein supplementation study is relatively straightforward. In patients with stroke who are able to take oral nutrition (undernourished or not), additional nutritional supplements beyond a normal hospital diet are probably not necessary. However, the other 2 trials require more thought.
The early ETF vs no ETF trial reassures me that no compelling urgency exists to start artificial nutrition in patients with dysphagic stroke. If I need a few additional days to discuss with patients or families the risks and benefits of artificial versus natural nutrition, I have them, keeping in mind that some form of nutrition should be started within the first week. Although I am reassured that NG feedings were not associated with a higher rate of aspiration pneumonia, I am constantly reminded of them being a nuisance every time I use them. In addition, the higher occurrence of gastrointestinal hemorrhages associated with their use (22 in the early ETF vs 11 in the no ETF group, P = 0.04), as found in the study, gives me further pause in ordering them.
The NG vs PEG trial shows that PEG tubes should not be used immediately, but only after an initial 2- to 3-week time-limited trial of NG feeding, allowing the necessary time for patients to resume natural nutrition. Indeed, of the 159 patients originally randomized to NG feeding, only 44 (28%) later received a PEG tube. If artificial nutrition is required beyond 2 to 3 weeks, then PEG feeding is the preferred approach. Previous clinical trials have shown that for patients with persistent dysphagia lasting ≥ 2 weeks, PEG tubes were not only safer (1, 2) but potentially associated with better survival at 6 weeks compared with NG feeding (88% in the PEG group vs 43% in the NG group) (2). Although the previous trials have methodologic shortcomings typical of unblinded trials with small sample sizes, they complement the data from the FOOD trials given that they ask different questions about the timing of PEG tube placement.
The FOOD trials do not, however, address the most challenging aspect of artificial nutrition in patients with stroke: not what or when—but if—artificial nutrition and PEG tubes should be used, because many patients have strong preferences regarding their use (3). The symbolic association of feeding tubes with disability and dependence is borne out by these studies, because 40% to 50% of patients did not survive to 6 months and of those who did, 65% had severe disability (MRS score 4 to 5), 20% had moderate disability (MRS score 3), and only 15% had no or slight disability (MRS score 0 to 2). Eliciting patient preferences regarding the use of feeding tubes and negotiating alternatives, such as hand-feeding (the true risks and benefits are unknown in this population), require intense discussions with concepts and words that most find uncomfortable but are critical for establishing the proper goals of care.
The FOOD trials provide us with a solid foundation of evidence. The marker of good care, however, will be that the treatment patients with dysphagic stroke receive is consistent with the underlying values of what makes their lives worth living.
Robert Holloway, MD, MPH
University of Rochester Medical Center
Rochester, New York, USA
1. Park RH, Allison MC, Lang J, et al. Randomized comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persistent neurological dysphagia. BMJ. 1992;304;1406-9. [PubMed ID: 1628013]
2. Norton B, Homer-Ward M, Donnelly MT, Long RG, Holmes GK. A randomized prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ. 1996;312:13-6. [PubMed ID: 8555849]